Proteomics

Dataset Information

0

Molecular Insights into Long COVID: Plasma Proteomics Reveals Oxidative Stress, Coagulation Cascade Activation, and Glycolytic Imbalance


ABSTRACT: Persistent symptoms following SARS-CoV-2 infection are the hallmark of post-COVID condition (PCC), also referred to as long COVID. However, our knowledge is limited on the underlying molecular mechanisms. In this study, we performed data-independent acquisition mass spectrometry plasma proteomics (DIA-MS) to identify molecular alterations associated with PCC. DIA-MS proteomic analysis revealed a few proteins linked to oxidative stress that had altered expression. Notably, PCC samples exhibited downregulation of the antioxidant protein peroxiredoxin 6 (PRDX6) and upregulation of oxidative stress-associated proteins particularly vanin-1 (VNN1) and paraoxonase-3 (PON3). Additionally, the PCC group showed significantly higher levels of six proteins (PCSK9, CST3, C1Q, CPB2, KNG1 GAPDH), which were linked to pathways involving glycolysis, complement and coagulation cascades, and inflammation. Oxidative stress analysis confirmed that PCC samples had significantly higher levels of DNA damage (8-OHdG) than the convalescent group, whereas antioxidant markers, such as reduced and oxidized glutathione (GSH and GSSG), were significantly lower in PCC samples than in uninfected controls. Our observations point towards ongoing oxidative and inflammatory processes in PCC and suggest potential targets for biomarker development and therapeutic intervention.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

DISEASE(S): Long Covid

SUBMITTER: Jean-Francois Lucier  

LAB HEAD: Sheela Ramanathan

PROVIDER: PXD066724 | Pride | 2026-03-24

REPOSITORIES: Pride

Dataset's files

Source:

Similar Datasets

2024-10-17 | PXD047623 | Pride
2024-05-22 | PXD047908 | Pride
2025-12-19 | PXD060523 | Pride
2025-11-03 | PXD063320 | Pride
2025-06-30 | PXD055852 | Pride
2026-04-14 | PXD051982 | Pride
2026-04-14 | PXD051948 | Pride
2024-08-29 | PXD047856 | Pride
2026-01-05 | PXD072314 | Pride
2025-01-24 | PXD056492 | Pride